Scientific evaluation of Basti therapy in the treatment of Prostate
Phase 2
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2020/10/028309
- Lead Sponsor
- IMS BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed case of Benign Enlargement of prostate
Exclusion Criteria
Neurogenic bladder
Uretheral Stricture
Carcinoma Prostate
Uncontrolled Diabetes Mellitus
Subjects with ARF and CRF
Subjects with Venereal Diseases
HIV & HBsAg positive subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method